Zoetis (ZTS) EPS (Basic) Growth (1y) (2013 - 2026)
Zoetis (ZTS) EPS (Basic) Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -99.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.45% |
| Mar 31, 2026 | 5.87% |
| Dec 31, 2025 | 6.30% |
| Sep 30, 2025 | 6.54% |
| Jun 30, 2025 | 17.75% |
| Mar 31, 2025 | 2.84% |
| Dec 31, 2024 | 12.80% |
| Sep 30, 2024 | 18.00% |
| Jun 30, 2024 | -5.56% |
| Mar 31, 2024 | 10.02% |
| Dec 31, 2023 | 15.60% |
| Sep 30, 2023 | 14.72% |
| Jun 30, 2023 | 28.88% |
| Mar 31, 2023 | -5.50% |
| Dec 31, 2022 | 12.68% |
| Sep 30, 2022 | -3.08% |
| Jun 30, 2022 | 4.58% |
| Mar 31, 2022 | 7.20% |
| Dec 31, 2021 | 15.64% |
| Sep 30, 2021 | 15.60% |